ArticleJAMA2025
Prevalence and Control of Diabetes Among US Adults, 2013 to 2023.
Article in JAMA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Cardiometabolic health of low- and higher-income adults in the United States, 2009-2023.American heart journal · 2026Article
- Recognition and control gaps in advanced cardiovascular-kidney-metabolic syndrome among United States adults.Preventive medicine reports · 2026Article
- Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome.Journal of the American College of Cardiology · 2026Article
- Hypercortisolism in Type 2 Diabetes with Treatment-Resistant Hyperglycemia: A Treatable Metabolic Phenotype?Endocrinology and metabolism (Seoul, Korea) · 2026Article
- Cardiovascular Risk Factor Prevalence and Control by Education Strata in Older Adults in 3 Countries.JAMA network open · 2026Article
- Obesity mediates the association of outdoor artificial light at night with type 2 diabetes mellitus.iScience · 2026Article
- Validation of a Diabetes Subtype Classification Model Using Data from U.S. Adults Before and After the COVID-19 Pandemic.Metabolites · 2026Article
- Social, psychosocial, and lifestyle determinants of diabetes and prediabetes in US adults before and after COVID-19: a cross-sectional NHANES analysis.Diabetology & metabolic syndrome · 2026Article
- Temporal trends and projected mortality of myocardial infarction and heart failure in the United States, 1999-2035: a CDC WONDER analysis.Frontiers in cardiovascular medicine · 2026Article
- Development of a novel web-based platform to support culturally and medically tailored comprehensive nutrition assessments: SPICE-Healthcare.JAMIA open · 2025Article
- ADD2Dia: Real-World Clinical Effectiveness of Adding a Sodium-Glucose Cotransporter 2 Inhibitor to Gliclazide-Based Therapy in Type 2 Diabetes.Advances in therapy · 2025Article
- Diabetes prevalence and management patterns in US adults, 2001-2023.Acta diabetologica · 2025Article
- Cardiovascular Risk Factor Management in Medicare Advantage and Traditional Medicare.Circulation. Cardiovascular quality and outcomes · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.